Tenaya Therapeutics, Inc. Payments for (Proceeds from) Other Investing Activities
Tenaya Therapeutics, Inc. (TNYA) reported Payments for (Proceeds from) Other Investing Activities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-03-11
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $0.00.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was $0.00.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2024-09-30 was -$12.00K, a 400.00% decline year-over-year.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for fiscal 2025 was $0.00.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for fiscal 2024 was -$17.00K, a 168.00% decline from fiscal 2023.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for fiscal 2023 was $25.00K.
- Tenaya Therapeutics, Inc. payments for (proceeds from) other investing activities for fiscal 2022 was -$8.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$12.00K derived: sum of 2 quarters · filed 2026-03-11 | -$16.00K derived: sum of 3 quarters · filed 2026-03-11 | -$17.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$16.00K derived: sum of 2 quarters · filed 2025-11-10 | -$17.00K 10-Q · filed 2025-11-10 | $1.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$5.00K 10-Q · filed 2025-08-06 | $13.00K derived: sum of 3 quarters · filed 2025-08-06 | $17.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-07 | $17.00K derived: sum of 2 quarters · filed 2025-05-07 | $21.00K derived: sum of 3 quarters · filed 2025-05-07 | $12.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $22.00K derived: sum of 2 quarters · filed 2025-03-10 | $13.00K derived: sum of 3 quarters · filed 2025-03-10 | $25.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$5.00K derived: sum of 2 quarters · filed 2024-11-06 | $7.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $12.00K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$8.00K 10-K · filed 2024-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |